Company Filing History:
Years Active: 2009-2010
Title: Seiichi Ikeyama: Innovator in Chemical Compounds
Introduction
Seiichi Ikeyama is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of chemical compounds, particularly in the development of innovative antioxidants and production processes.
Latest Patents
Ikeyama holds 2 patents that showcase his expertise. His latest patents include a diamine derivative and its production process, which relates to a compound represented by a specific formula. This invention also encompasses an antioxidant that serves as an active ingredient in various medical applications, including treatments for kidney diseases and cerebrovascular disorders. Another patent focuses on phenylazole compounds and their production process, further highlighting his innovative approach to chemical development.
Career Highlights
Ikeyama is associated with Nippon Soda Co., Ltd., where he has been instrumental in advancing research and development in chemical compounds. His work has not only contributed to the company's portfolio but has also had a broader impact on the industry.
Collaborations
Throughout his career, Ikeyama has collaborated with esteemed colleagues such as Nobuhiro Umeda and Nobuo Mochizuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Seiichi Ikeyama's contributions to the field of chemical compounds and antioxidants demonstrate his commitment to innovation. His patents reflect a deep understanding of chemistry and its applications in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.